Prognostic value of BRAF/MIR‐17 signature and B‐Raf protein expression in patients with colorectal cancer: A pilot study

BACKGROUND: Despite the recent improvement in colorectal cancer (CRC) treatment, it still has a poor prognosis with a low survival rate. Genetic and epigenetic mechanisms have proved to play a substantial role in CRC tumorigenesis and progression. According to Gene Ontology and TargetScan analyses,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahiem, Afaf T., Fawzy, Manal S., Abu AlSel, Baraah T., Toraih, Eman A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957984/
https://www.ncbi.nlm.nih.gov/pubmed/33296098
http://dx.doi.org/10.1002/jcla.23679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957984/
https://www.ncbi.nlm.nih.gov/pubmed/33296098
http://dx.doi.org/10.1002/jcla.23679

Ejemplares similares